This webinar will help participants better understand the information on FDA-approved drug labels, particularly in the post-approval experience section. Presenters will share findings from a 2019 survey of AVMA and NAVTA members on how drug labels are used and understood. They'll also explain how the findings can help improve the way a product’s safety information is conveyed. Come away knowing how to make more informed decisions about medication and product safety. 

This course is not available for CE Credit
Free for AVMA/SAVMA Members
$25 Non-members